Changes in gut bacterial populations and their translocation into liver and ascites in alcoholic liver cirrhotics
© Tuomisto et al.; licensee BioMed Central Ltd. 2014
Received: 9 October 2013
Accepted: 19 February 2014
Published: 24 February 2014
The liver is the first line of defence against continuously occurring influx of microbial-derived products and bacteria from the gut. Intestinal bacteria have been implicated in the pathogenesis of alcoholic liver cirrhosis. Escape of intestinal bacteria into the ascites is involved in the pathogenesis of spontaneous bacterial peritonitis, which is a common complication of liver cirrhosis. The association between faecal bacterial populations and alcoholic liver cirrhosis has not been resolved.
Relative ratios of major commensal bacterial communities (Bacteroides spp., Bifidobacterium spp., Clostridium leptum group, Enterobactericaea and Lactobacillus spp.) were determined in faecal samples from post mortem examinations performed on 42 males, including cirrhotic alcoholics (n = 13), non-cirrhotic alcoholics (n = 15), non-alcoholic controls (n = 14) and in 7 healthy male volunteers using real-time quantitative PCR (RT-qPCR). Translocation of bacteria into liver in the autopsy cases and into the ascites of 12 volunteers with liver cirrhosis was also studied with RT-qPCR. CD14 immunostaining was performed for the autopsy liver samples.
Relative ratios of faecal bacteria in autopsy controls were comparable to those of healthy volunteers. Cirrhotics had in median 27 times more bacterial DNA of Enterobactericaea in faeces compared to the healthy volunteers (p = 0.011). Enterobactericaea were also the most common bacteria translocated into cirrhotic liver, although there were no statistically significant differences between the study groups. Of the ascites samples from the volunteers with liver cirrhosis, 50% contained bacterial DNA from Enterobactericaea, Clostridium leptum group or Lactobacillus spp.. The total bacterial DNA in autopsy liver was associated with the percentage of CD14 expression (p = 0.045). CD14 expression percentage in cirrhotics was significantly higher than in the autopsy controls (p = 0.004).
Our results suggest that translocation of intestinal bacteria into liver may be involved as a one factor in the pathogenesis of alcoholic liver cirrhosis.
KeywordsAlcoholic liver cirrhosis Gut microbiota RT-qPCR Bacterial translocation Microbiology CD14
Liver cirrhosis is the irreversible end stage of chronic liver disease. In Western countries more than 90% of cirrhosis is caused by excessive ethanol consumption. However, only a minority of alcohol abusers ever develop liver cirrhosis during their lives. Our group has previously reported a link between alcoholic liver cirrhosis and bacterial recognition receptor CD14 genetics  supporting the hypothesis of the involvement of intestinal bacteria and their endotoxins in the pathogenesis of cirrhosis . This observation has been confirmed by other groups [3, 4].
In healthy individuals, normal gut microbiota consists mainly of bacteria belonging to the Clostridium coccoides (cluster XIVa) and Clostridium leptum group (cluster IV), Bacteroides spp., Bifidobacterium spp. and Enterobacter spp. [5, 6]. Enterobacter spp. belongs to a large Enterobactericaea family consisting of several gram-negative bacteria . The liver is continually exposed to gut derived bacteria and bacterial components because ca. 70% of its blood supply is from the portal vein, which is the direct venous outflow of the intestine . Chronic alcohol abuse has been shown to change intestinal bacterial population by decreasing the numbers of Clostridium (gram-positive, anaerobe) and Bacteroidetes (gram-negative, anaerobe) and increasing the numbers of aerobic Proteobacteria (gram-negative, facultatively or obligately anaerobic) .
Alcohol can cause leakage of intestinal cell junctions . Gram-negative bacteria  and their endotoxins  may then translocate through portal blood into the liver and induce inflammation leading to fibrosis and cirrhosis in genetically susceptible individuals . The quantities of Bacteroides spp. and Bifidobacterium spp. have been reported to be decreased and those of Enterobacter spp. and Clostridium spp. to be increased in the faeces of cirrhotics [13, 14], but it is not known whether these bacteria may translocate into the liver.
Spontaneous bacterial peritonitis is a complication of cirrhosis. It is thought to be due to bacterial overgrowth in the gut and their translocation into the ascites . Its frequency has been 7% in cirrhotic patients with ascites . Bacterial culture is unreliable, and the diagnosis is based on a polymorphonuclear cell count of 250/mm3 or more in the ascites fluid, regardless of the result of received by bacterial culturing. Bacterial contamination may be far more common than manifest in spontaneous bacterial peritonitis or positive bacterial culture. It is possible that bacteria which may be associated with the pathogenesis of cirrhosis may also be present in ascites when measured by molecular biological methods instead of conventional culturing.
We have previously reported that liver samples from autopsies can be reliably used in bacteriological analyses up to 5 days post mortem , and that the faecal bacterial composition of certain bacteria remains stable during that period . In an earlier paper we also have shown in the present autopsy series that bacteria can be detected by culturing and qPCR in mesenteric lymph nodes but also in the portal vein and liver . The aim of this study was to characterize changes in intestinal microbiota (Bacteroides spp., Bifidobacterium spp., Clostridium leptum group, Enterobacteriacaea, and Lactobacillus spp.) in alcoholic liver cirrhotics compared to alcoholics without cirrhosis, non-alcoholic autopsy controls and in healthy volunteers, and to study the translocation of bacteria into liver and ascites samples. In order to confirm the significance of our bacterial findings, the activity of bacteria recognizing receptor CD14 was studied by immunostaining of autopsy liver samples and correlated with the presence and amount of bacterial DNA in liver.
Demographic characteristics of the study subjects
PM time mean
Age mean (range)
BMI mean (range
Cause of death
Written consent was obtained from the volunteers. None of the healthy volunteers drank more than 3 drinks (12 g of alcohol) per week. Volunteers with liver cirrhosis reported excessive alcohol consumption. None of the study subjects were reported to have taken antibiotics for 2 weeks prior to sampling.
Samples from rectum and liver were taken aseptically from the autopsy cases. The healthy volunteers provided samples after defecation. All faecal samples were frozen (−20°C) immediately after sampling and were transferred to −80°C until further processing. Ascites fluid samples were collected from patients during their hospital stay with sterile instruments.
Ascites fluid samples were drawn aseptically at the bedside from the volunteers with a diagnosis of alcohol-related cirrhosis, which was based on drinking history and clinical findings. Bacterial conventional culturing as well as albumin and polymorphonuclear measurements from ascites samples were performed.
Faecal samples were weighed to be 150 mg (wet weight). Bacterial DNA was extracted from the faecal samples using a commercial DNA extraction kit (Zymo Fecal DNA Kit (Zymo Research Corporation, Irvine, California, USA)) according to the instructions provided. DNA from liver, blood and ascites fluid samples was extracted using Zymo Bacterial/Fungal DNA Kit (Zymo Bacterial/Fungal DNA Kit (Zymo Research Corporation, Irvine, California, USA)).
The quantity of bacteria was determined by RT-qPCR using published oligonucleotide primers and probes for Bacteroides spp. , Bifidobacterium spp. , Clostridium leptum group (cluster IV) , and Enterobacter spp. . The primers and probe for Enterobacteriacaea (Forward: GCGGTAGCACAGAGAGCTT, Reverse: GGCAGTTTCCCAGACATTACTCA, PROBE:6FAM-CCGCCGCTCGTCACC-BHQ), and Lactobacillus spp. (Forward: GCTAGGTGTTGGAGGGTTTCC, Reverse: CCAGGCGGAATGCTTAATGC, PROBE:6FAM- TCAGTGCCGCAGCTAA-BHQ) were designed and confirmed using BLAST with the National Centre for Biotechnology Information server (http://www.ncbi.nlm.nih.gov) and Ribosomal Database Project (http://rdp.cme.msu.edu/probematch/search.jsp). Specificity and cross reactivity of all the primers and probes were tested using bacteria from clinical samples and reference bacteria [16, 21]. Total amount of bacteria was measured using universal bacterial primers and a probe . Assays from faecal samples and from ascites were performed with AbiPrism 7000 HT Sequence Detection System (Taqman™, AppliedBiosystems, California, USA) in reaction volume of 20 μl in 96-well reaction plate under standard conditions with Taqman. Faecal samples were diluted 1:100. In the liver samples, assays were performed with AbiPrism 7900 HT Sequence Detection System (Taqman®, AppliedBiosystems) in a reaction volume of 5 μl. One micro litre of DNA was added into the reactions for the detection system. MasterMix was prepared using Taqman™ Environmental MasterMix adding at final concentrations of 1000 nM of each primer, and 250 nM of each fluorescence labelled probe. All amplifications and detections were carried out in duplicate or quadruplicate (in uncertain cases).
The relative amount of bacterial DNA in a sample was determined with comparative Ct method (ΔΔCt, ΔCt sample – ΔCt reference sample) . In autopsy faecal samples, mean ΔC values of the faecal samples of healthy volunteers were calculated and used as a reference. In ascites fluid and liver samples the blood sample from a healthy individual was used as a reference as previously described . Bacterial positivity of liver and ascites samples was determined as previously described .
Histological samples from the right lobe of the liver were taken at autopsy, fixed in 10% formalin overnight and processed for CD14 (Leica Biosystems, Newcastle, United Kingdom) immunohistochemistry, using dilution of 1:250 with Autostainer LV-1 (Lab Vision Corporation, California, USA). The percentage of brown peroxidase positivity in each sample was calculated with the ImmunoRatio program  and average discolouration value was compared between different groups.
The study was approved by the Ethics Committee of Pirkanmaa Hospital District and the National Supervisory Authority for Welfare and Health (VALVIRA).
Due to the skewed variation within the bacterial measurements, logarithmic values were used for the calculations [IBM SPSS Statistics version 21 (IBM, New York, United States)]. ANOVA was used to measure significant differences between groups (healthy volunteers, alcoholic cirrhotics, alcoholics and non-alcoholic controls). When ANOVA showed a significant difference, pairwise comparisons with Post Hoc test with Least Significant Difference (LSD) corrections were made. With liver samples, Pearson’s Chi-square test was used.
In this study we measured with RT-qPCR the composition of gut microbiota and bacterial translocation into the liver in alcoholic liver cirrhotics and non-cirrhotic alcoholics compared to controls. We found that liver cirrhotics harboured considerably more gram-negative Bacteroides and Enterobactericaea including Enterobacter spp. in their faeces than did the controls. This result is in line with those of other studies [13, 14, 25] showing increased prevalence of Enterobactericaea in the phylum level and also an increase in the counts of Enterobacter spp. in the faeces of cirrhotics. Cirrhosis is associated with a decreased conversion of primary to secondary faecal bile acids, which is associated with abundance of major gut microbiome taxa. Bile acids in general, and cholestasis, which is common in cirrhotic patients, may be one mechanistic explanation for the altered microbiota in liver diseases . However, our results do not confirm earlier reports of decreased amounts of gram-negative Bacteroides spp. and gram-positive Bifidobacterium spp. and increased amounts of gram-positive Clostridium spp. in the faeces of cirrhotics [13, 14,].
We also found that the total amount of bacterial DNA in liver was associated with CD14 expression percentage in immunohistochemical stainings. The CD14 expression percentage in cirrhotics was significantly higher due to possible bacterial load compared to that of the autopsy controls. While CD14 macrophages in liver, Kupffer cells, are also capable of recognizing e.g. human cell debris, apoptotic cells and other activating agents , they have developed an efficient phagocytic capacity to remove endotoxin from portal circulation. Moreover, since Kupffer cells are continuously exposed to endotoxin and other activators, they show constitutive low-level CD14 activation , as is seen in our control liver samples. As far as we know, there are no previous studies reporting the simultaneous measurement of amounts of bacterial DNA and CD14 activity in the liver. Our results suggest that bacteria may have a role as inducers of the CD14 mediated inflammation process that may lead to fibrosis and cirrhosis .
It is known that intestinal bacteria contribute to intestinal homeostasis and that alcohol affects microbial populations by disturbing this balance . Alcohol metabolite, acetaldehyde, has a direct effect on gut epithelial cell function by disrupting tight junctions, and may thus enhance bacterial translocation  from the intestines. Alcohol ingestion has been reported to correlate with increased levels of bacterial endotoxins [29–31] and peptidoglycan  in plasma. Of commensal intestinal bacteria, gram-negative enterobacteria and gram-positive enterococci are the most effective to escape into the organs  and are the most commonly found in community-acquired infections in patients with alcoholic liver cirrhosis . Moreover, sepsis is a 20 times more common cause of death in cirrhotics than in general population . Our results showed that Enterobactericaea was the most commonly detected in livers of cirrhotics. These differences were not statistically significant, most probably due to small sample size and wide inter-individual variations in bacterial populations. Furthermore, bacterial DNA from Enterobactericaea was also detected in ascites.
In cirrhotic patients, attempts have been made to inhibit the growth of gram-negative bacteria in the gut by the use of broad-spectrum antibiotics such as fluorokinones e.g. neomysin, norfloxacin and ciprofloxacin [35, 36]. However, long-term use of antibiotics may lead to an increase of pathogenic bacteria in the gut  and to increased antibiotic resistance [38, 39]. In experimental studies, probiotics (Bifidobacterium spp., Lactobacillus spp.), have restored normal gut homeostasis and have inhibited excessive growth of gram-negative bacteria [40–42]. In the future, targeted treatments using probiotics or better focused antibiotics against risk pathogens, like Enterobactericaea, may be available.
In the present study, relative amounts of commensal gut bacteria and their translocation into liver and ascites was investigated with RT-qPCR. The frequency of bacterial DNA in ascites was 50%, even though none of the volunteers with liver cirrhosis had positive culture or spontaneous bacterial peritonitis. We used universal bacterial primers and probes  to amplify all bacterial DNA in the samples. Therefore we believe that our negative cases were genuinely bacterial negative and ascites were sterile in these cases. We did not have control samples from non-cirrhotic ascites, which is a limitation of the study, but except in malignancy, such samples are difficult to obtain. Nevertheless, the same bacteria were found to leak in ascites which were found translocated in liver samples. RT-qPCR provides a fast and accurate tool for the determination of the faecal bacterial composition of clinical patients. Conventional culturing, which is used in many hospital labs, provides only limited opportunities to study certain bacterial strains . Culturing is a relatively slow method and may not provide any information if the bacteria in the samples have been exposed to unfavourable conditions like oxygen or temperature changes leading to their death. Because only 30-40% of the bacteria in the human intestinal tract are culturable, bacterial detection diagnostics can be improved with the DNA-detection based approach . We also found that there were remarkable inter-individual variations in bacterial population ratios, as also reported by earlier studies [44, 45].
We have previously shown that e.g. genetic polymorphism in the bacterial CD14 receptor may play a role in susceptibility to cirrhosis . This suggests that susceptibility to alcoholic liver cirrhosis due to bacterial influx into the liver may also be genetically determined. A continuous bacterial translocation from the gut may not be enough per se to cause the development of cirrhosis.
In conclusion, alcoholic liver cirrhotics had increased amounts of gram-negative enterobacteria in faeces and DNA from enterobacteria was detected in liver and ascites. Total bacterial DNA amount in the liver was associated with immunohistochemical CD14 expression, which was significantly higher in liver cirrhotics than in autopsy controls.
These results suggest that intestinal microbiota and bacterial translocation into the liver may be involved in the pathogenesis of alcoholic liver cirrhosis.
Real-time quantitative polymerase chain reaction.
The excellent technical assistance from the personnel of Department of Forensic Medicine, especially Kari Mänttäri, Olli Penttilä and Mervi Seppänen, Tampere University is gratefully acknowledged. We also appreciate the participation of the volunteers and the personnel of the Tampere University Hospital.
The study was financially supported by the Tampere Graduate Program in Biomedicine and Biotechnology (TGPBB), the Finnish Foundation for Alcohol Studies, Foundation of Mary and Georg C. Ehrnrooth, the Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital, the European Union 7th Framework Program grant number 201668 for the AtheroRemo Project, the Pirkanmaa Regional Fund of the Finnish Cultural Foundation.
- Jarvelainen HA, Orpana A, Perola M, Savolainen VT, Karhunen PJ, Lindros KO: Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology. 2001, 33: 1148-1153. 10.1053/jhep.2001.24236.View ArticlePubMedGoogle Scholar
- Yan AW, Schnabl B: Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease. World J Hepatol. 2012, 4: 110-118. 10.4254/wjh.v4.i4.110.View ArticlePubMedPubMed CentralGoogle Scholar
- Campos J, Gonzalez-Quintela A, Quinteiro C, Gude F, Perez LF, Torre JA, Vidal C: The -159C/T polymorphism in the promoter region of the CD14 gene is associated with advanced liver disease and higher serum levels of acute-phase proteins in heavy drinkers. Alcohol Clin Exp Res. 2005, 29: 1206-1213. 10.1097/01.ALC.0000171977.25531.7A.View ArticlePubMedGoogle Scholar
- LeVan TD, Bloom JW, Bailey TJ, Karp CL, Halonen M, Martinez FD, Vercelli D: A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol. 2001, 167: 5838-5844.View ArticlePubMedGoogle Scholar
- Lay C, Sutren M, Rochet V, Saunier K, Dore J, Rigottier-Gois L: Design and validation of 16S rRNA probes to enumerate members of the Clostridium leptum subgroup in human faecal microbiota. Environ Microbiol. 2005, 7: 933-946. 10.1111/j.1462-2920.2005.00763.x.View ArticlePubMedGoogle Scholar
- Orrhage K, Nord CE: Bifidobacteria and lactobacilli in human health. Drugs Exp Clin Res. 2000, 26: 95-111.PubMedGoogle Scholar
- Williams KP, Gillespie JJ, Sobral BW, Nordberg EK, Snyder EE, Shallom JM, Dickerman AW: Phylogeny of gammaproteobacteria. J Bacteriol. 2010, 192: 2305-2314. 10.1128/JB.01480-09.View ArticlePubMedPubMed CentralGoogle Scholar
- Son G, Kremer M, Hines IN: Contribution of gut bacteria to liver pathobiology. Gastroenterol Res Pract. 2010, 2010: doi:10.1155/2010/453563. Epub 2010 Jul 28Google Scholar
- Mutlu EA, Gillevet PM, Rangwala H, Sikaroodi M, Naqvi A, Engen PA, Kwasny M, Lau CK, Keshavarzian A: Colonic microbiome is altered in alcoholism. Am J Physiol Gastrointest Liver Physiol. 2012, 302: G966-G978. 10.1152/ajpgi.00380.2011.View ArticlePubMedPubMed CentralGoogle Scholar
- Basuroy S, Sheth P, Mansbach CM, Rao RK: Acetaldehyde disrupts tight junctions and adherens junctions in human colonic mucosa: protection by EGF and L-glutamine. Am J Physiol Gastrointest Liver Physiol. 2005, 289: G367-G375. 10.1152/ajpgi.00464.2004.View ArticlePubMedGoogle Scholar
- Steffen EK, Berg RD, Deitch EA: Comparison of translocation rates of various indigenous bacteria from the gastrointestinal tract to the mesenteric lymph node. J Infect Dis. 1988, 157: 1032-1038. 10.1093/infdis/157.5.1032.View ArticlePubMedGoogle Scholar
- Schaffert CS, Duryee MJ, Hunter CD, Hamilton BC, DeVeney AL, Huerter MM, Klassen LW, Thiele GM: Alcohol metabolites and lipopolysaccharide: roles in the development and/or progression of alcoholic liver disease. World J Gastroenterol. 2009, 15: 1209-1218. 10.3748/wjg.15.1209.View ArticlePubMedPubMed CentralGoogle Scholar
- Zhao HY, Wang HJ, Lu Z, Xu SZ: Intestinal microflora in patients with liver cirrhosis. Chin J Dig Dis. 2004, 5: 64-67. 10.1111/j.1443-9573.2004.00157.x.View ArticlePubMedGoogle Scholar
- Chen Y, Yang F, Lu H, Wang B, Chen Y, Lei D, Wang Y, Zhu B, Li L: Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology. 2011, 54: 562-572. 10.1002/hep.24423.View ArticlePubMedGoogle Scholar
- Khan J, Pikkarainen P, Karvonen AL, Mäkelä T, Peräaho M, Pehkonen E, Collin P: Ascites: aetiology, mortality and the prevalence of spontaneous bacterial peritonitis. Scand J Gastroenterol. 2009, 44: 970-974. 10.1080/00365520902964739.View ArticlePubMedGoogle Scholar
- Tuomisto S, Karhunen PJ, Vuento R, Aittoniemi J, Pessi T: Evaluation of postmortem bacterial migration using culturing and real-time quantitative PCR. J Forensic Sci. 2013, 58: 910-916. 10.1111/1556-4029.12124.View ArticlePubMedGoogle Scholar
- Tuomisto S, Karhunen PJ, Pessi T: Time-dependent post mortem changes in the composition of intestinal bacteria using real-time quantitative PCR. Gut Pathogens. 2013, 5: 35-10.1186/1757-4749-5-35.View ArticlePubMedPubMed CentralGoogle Scholar
- Brunk CF, Li J, Avaniss-Aghajani E: Analysis of specific bacteria from environmental samples using a quantitative polymerase chain reaction. Curr Issues Mol Biol. 2002, 4: 13-18.PubMedGoogle Scholar
- Furet JP, Firmesse O, Gourmelon M, Bridonneau C, Tap J, Mondot S, Doré J, Corthier G: Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol Ecol. 2009, 68: 351-362. 10.1111/j.1574-6941.2009.00671.x.View ArticlePubMedGoogle Scholar
- Sen K, Asher DM: Multiplex PCR for detection of Enterobacteriaceae in blood. Transfusion. 2001, 41: 1356-1364. 10.1046/j.1537-2995.2001.41111356.x.View ArticlePubMedGoogle Scholar
- Pessi T, Karhunen V, Karjalainen PP, Ylitalo A, Airaksinen JK, Niemi M, Pietila M, Lounatmaa K, Haapaniemi T, Lehtimäki T, Laaksonen R, Karhunen PJ, Mikkelsson J: Bacterial signatures in thrombus aspirates of patients with myocardial infarction. Circulation. 2013, 127: 1219-1228. 10.1161/CIRCULATIONAHA.112.001254.View ArticlePubMedGoogle Scholar
- Yang S, Lin S, Kelen GD, Quinn TC, Dick JD, Gaydos CA, Rothman RE: Quantitative multiprobe PCR assay for simultaneous detection and identification to species level of bacterial pathogens. J Clin Microbiol. 2002, 40: 3449-3454. 10.1128/JCM.40.9.3449-3454.2002.View ArticlePubMedPubMed CentralGoogle Scholar
- Suzuki N, Yoshida A, Nakano Y: Quantitative analysis of multi-species oral biofilms by TaqMan real-time PCR. Clin Med Res. 2005, 3: 176-185. 10.3121/cmr.3.3.176.View ArticlePubMedPubMed CentralGoogle Scholar
- Tuominen VJ, Ruotoistenmaki S, Viitanen A, Jumppanen M, Isola J: ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Breast Cancer Res. 2010, 12: R56-10.1186/bcr2615.View ArticlePubMedPubMed CentralGoogle Scholar
- Kakiyama G, Pandak WM, Gillevet PM, Hylemon PB, Heuman DM, Daita K, Takei H, Muto A, Nittono H, Ridlon JM, White MB, Noble NA, Monteith P, Fuchs M, Thacker LR, Sikaroodi M, Bajaj JS: Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. J Hepatol. 2013, 58: 949-955. 10.1016/j.jhep.2013.01.003.View ArticlePubMedPubMed CentralGoogle Scholar
- Hume DA, Ross IL, Himes SR, Sasmono RT, Wells CA, Ravasi T: The mononuclear phagocyte system revisited. J Leukoc Biol. 2002, 72: 621-627.PubMedGoogle Scholar
- Laskin DL, Weinberger B, Laskin JD: Functional heterogeneity in liver and lung macrophages. J Leukoc Biol. 2001, 70: 163-170.PubMedGoogle Scholar
- Levy E, Xanthou G, Petrakou E, Zacharioudaki V, Tsatsanis C, Fotopoulos S, Xanthou M: Distinct roles of TLR4 and CD14 in LPS-induced inflammatory responses of neonates. Pediatr Res. 2009, 66: 179-184. 10.1203/PDR.0b013e3181a9f41b.View ArticlePubMedGoogle Scholar
- Adachi Y, Moore LE, Bradford BU, Gao W, Thurman RG: Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology. 1995, 108: 218-224. 10.1016/0016-5085(95)90027-6.View ArticlePubMedGoogle Scholar
- Nanji AA, Khettry U, Sadrzadeh SM, Yamanaka T: Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. Am J Pathol. 1993, 142: 367-373.PubMedPubMed CentralGoogle Scholar
- Tamai H, Kato S, Horie Y, Ohki E, Yokoyama H, Ishii H: Effect of acute ethanol administration on the intestinal absorption of endotoxin in rats. Alcohol Clin Exp Res. 2000, 24: 390-394. 10.1111/j.1530-0277.2000.tb04629.x.View ArticlePubMedGoogle Scholar
- Tabata T, Tani T, Endo Y, Hanasawa K: Bacterial translocation and peptidoglycan translocation by acute ethanol administration. J Gastroenterol. 2002, 37: 726-731. 10.1007/s005350200118.View ArticlePubMedGoogle Scholar
- Garcia-Tsao G: Spontaneous bacterial peritonitis. Gastroenterol Clin North Am. 1992, 21: 257-275.PubMedGoogle Scholar
- Vilstrup H: Cirrhosis and bacterial infections. Rom J Gastroenterol. 2003, 12: 297-302.PubMedGoogle Scholar
- Terg R, Fassio E, Guevara M, Cartier M, Longo C, Lucero R, Landeira C, Romero G, Dominguez N, Muñoz A, Levi D, Miguez C, Abecasis R: Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study. J Hepatol. 2008, 48: 774-779. 10.1016/j.jhep.2008.01.024.View ArticlePubMedGoogle Scholar
- Madrid AM, Hurtado C, Venegas M, Cumsille F, Defilippi C: Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function. Am J Gastroenterol. 2001, 96: 1251-1255. 10.1111/j.1572-0241.2001.03636.x.View ArticlePubMedGoogle Scholar
- Brandl K, Plitas G, Mihu CN, Ubeda C, Jia T, Fleisher M, Schnabl B, DeMatteo RP, Pamer EG: Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature. 2008, 455: 804-807. 10.1038/nature07250.View ArticlePubMedPubMed CentralGoogle Scholar
- Novella M, Solà R, Soriano G, Andreu M, Gana J, Ortiz J, Coll S, Sàbat M, Vila MC, Guarner C, Vilardell F: Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. Hepatology. 1997, 25: 532-536. 10.1002/hep.510250306.View ArticlePubMedGoogle Scholar
- Campillo B, Dupeyron C, Richardet JP, Mangeney N, Leluan G: Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxacin. Clin Infect Dis. 1998, 26: 1066-1070. 10.1086/520273.View ArticlePubMedGoogle Scholar
- Kirpich IA, Solovieva NV, Leikhter SN, Shidakova NA, Lebedeva OV, Sidorov PI, Bazhukova TA, Soloviev AG, Barve SS, McClain CJ, Cave M: Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol. 2008, 42: 675-682. 10.1016/j.alcohol.2008.08.006.View ArticlePubMedPubMed CentralGoogle Scholar
- Leber B, Spindelboeck W, Stadlbauer V: Infectious complications of acute and chronic liver disease. Semin Respir Crit Care Med. 2012, 33: 80-95.View ArticlePubMedGoogle Scholar
- Hartmann P, Chen WC, Schnabl B: The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease. Front Physiol. 2012, 3: 402-View ArticlePubMedPubMed CentralGoogle Scholar
- Hayashi H, Sakamoto M, Benno Y: Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods. Microbiol Immunol. 2002, 46: 535-548. 10.1111/j.1348-0421.2002.tb02731.x.View ArticlePubMedGoogle Scholar
- Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA: Diversity of the human intestinal microbial flora. Science. 2005, 308: 1635-1638. 10.1126/science.1110591.View ArticlePubMedPubMed CentralGoogle Scholar
- Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, Egholm M, Henrissat B, Heath AC, Knight R, Gordon JI: A core gut microbiome in obese and lean twins. Nature. 2009, 457: 480-484. 10.1038/nature07540.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-230X/14/40/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.